The Relationship of Serum S100B Levels with Infarction Size and Clinical Outcome in Acute Ischemic Stroke Patients

Selcuk O., Yayla V., Cabalar M., Guzel V., Uysal S., GEDİKBAŞI A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.51, no.4, pp.395-400, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 4
  • Publication Date: 2014
  • Doi Number: 10.5152/npa.2014.7213
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.395-400
  • Keywords: Brain, cerebrovascular disorders, biological markers, prognosis, NEURON-SPECIFIC ENOLASE, S-100 PROTEIN, BRAIN-DAMAGE, NEUROBIOCHEMICAL MARKERS, VOLUME, BLOOD
  • Istanbul University Affiliated: No


Introduction: S100B protein, which helps nerve development and differentiation, is produced by astrocytes and can be detected in peripheral circulation after brain damage. In this study, we aimed to investigate the relationship between the serum S100B protein level and the infarction volume and clinical outcome and also the early prognostic role of serum S100B protein in patients with ischemic stroke.